Sign In
Buy PFE
$25.69
+0.335 (+1.32%)
At Close: Jun 04, 2026
Better Beaten-Down Stock to Buy: Pfizer Vs. Moderna
08:30am, Thursday, 03'rd Apr 2025
In 2020, many companies tried to develop effective coronavirus vaccines, but two ended up succeeding and dominating the field: Pfizer (PFE 0.77%) and Moderna (MRNA 2.21%). These two vaccine makers mad
A Historic Opportunity For Dividend Investors
08:05am, Thursday, 03'rd Apr 2025
These overlooked stocks could be the next big AI winners—and they pay you to wait. Forget Nvidia: This is where the real AI-fueled upside may be hiding. Massive AI gains without the hype—discover
Is Pfizer Stock a Buy?
05:47am, Thursday, 03'rd Apr 2025
Pfizer's (PFE 0.77%) share price has fallen more than the S&P 500 so far this year. The big pharma stock is nearly 60% below its high set in late 2022.
2 Absurdly Cheap Stocks to Buy and Hold for Years
04:40am, Thursday, 03'rd Apr 2025
Buying stock in great companies when they are dealing with some short-term issue that creates stock price weakness can set investors up for big gains down the road. As long as the business is still in
Pfizer (PFE) Increases Yet Falls Behind Market: What Investors Need to Know
06:50pm, Wednesday, 02'nd Apr 2025
In the closing of the recent trading day, Pfizer (PFE) stood at $24.70, denoting a +0.65% change from the preceding trading day.
My Top 10 High-Yield Dividend Stocks For April 2025: One Yields 8%-Plus
06:00pm, Wednesday, 02'nd Apr 2025
Companies with attractive valuations, strong competitive advantages, and sustainable dividend growth can help investors steadily increase wealth while reducing risk. The selection process of my top 10
PFE, MRK, LLY & Other Drug Stocks Down Amid Tariff Jitters
10:46am, Wednesday, 02'nd Apr 2025
Stocks of PFE, MRK, ABBV, LLY and others declined on Tuesday due to uncertainty surrounding Trump's proposed tariffs on pharma imports.
Proxy adviser ISS recommends Pfizer shareholders to vote against CEO compensation
09:10am, Wednesday, 02'nd Apr 2025
Institutional Shareholder Services is recommending Pfizer's investors to reject a management proposal on annual compensation for CEO Albert Bourla and other executives, the proxy adviser said on Wedne
PFE Secures EU Nod for Expanded Use of RSV Vaccine Abrysvo
08:40am, Wednesday, 02'nd Apr 2025
The latest decision makes Pfizer's Abrysvo the first RSV vaccine approved for use in non-pregnant adults under 50 years of age in the EU.
Wall Street Says Sell US Market Rallies: Never Sell These 4 High-Yield Dividend Giants
07:47am, Wednesday, 02'nd Apr 2025
The “buy the dip” strategy worked flawlessly for over two years.
2 Healthcare Stocks to Watch as JPMorgan Boosts Gilead Rating
07:49pm, Tuesday, 01'st Apr 2025
When Wall Street analysts decide to come out of their caves and boost a certain stock, retail investors should pay attention to the motives behind the decision as it can signal a shift in sentiment to
2 Healthcare Stocks to Watch as JPMorgan Boosts Gilead Rating
07:48pm, Tuesday, 01'st Apr 2025
When Wall Street analysts decide to come out of their caves and boost a certain stock, retail investors should pay attention to the motives behind the decision as it can signal a shift in sentiment to
Why Major Pharmaceutical Stocks Tumbled on Tuesday
07:09pm, Tuesday, 01'st Apr 2025
Many investor eyes were on the pharmaceutical industry on Tuesday, and not necessarily for the right reasons. The Trump administration's promised tariffs were set to go into effect the following day,
Trump's tariffs are a new challenge for Big Pharma. Here are the best positioned stocks
02:01pm, Tuesday, 01'st Apr 2025
Leerink Partners analyst David Resinger warned his clients on Sunday that the tariff risks to the industry are 'underappreciated.'
Here is Why Everyone Should Own Schwab’s SCHD ETF
10:30am, Tuesday, 01'st Apr 2025
This post may contain links from our sponsors and affiliates, and Flywheel Publishing may receive compensation for actions taken through them. The current market uncertainty has sparked investor inter
